> MNTA up by 0.71$ (up by 4%). Mkt seems to have changed it's mind and thinks OK to have a non Phd :-)<
It could be that people became somewhat more bullish after studying the new CEO’s CV. Down 2% or up 4%, the main point is that it’s a relatively mild response to such a major announcement: a yawn, as rkrw said.
p.s. Anyone who thinks I am negative on MNTA is either stupid or hasn’t read my posts carefully. I think MNTA has a promising future, but they have to find a way to get through the Lovenox case in good shape. Biosimilar drugs are an area of interest for me, and I consider MNTA one of the important players.
Market Data 
Markets 
AI
